GlassScriptPhysician profile
Binav Shrestha
NPI 1801349691
$3,627.68
in general payments reported to CMS, 2019-2025
21 companies · $1,119 in 2025
The $1,119 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $38.45 · 2023: $1,976 · 2024: $494 · 2025: $1,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,343 · Travel and Lodging: $1,246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,343.10 |
| Travel and Lodging | $1,246.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,356.13 | 2023 | Single Use Suction Valve (Sterile) |
| Glaxosmithkline, LLC. | $882.93 | 2022-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $343.32 | 2025 | Airsupra, Breztri, Fasenra |
| United Therapeutics Corporation | $165.62 | 2024-2025 | Tyvaso, Tyvaso |
| Mallinckrodt Hospital Products INC. | $109.53 | 2024-2025 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.35 | 2023-2024 | Ofev, Jardiance |
| Boston Scientific Corporation | $97.40 | 2023 | Watchman Access System |
| Regeneron Healthcare Solutions, INC. | $83.65 | 2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $70.13 | 2024-2025 | Uptravi, Opsumit |
| Harmony Biosciences LLC | $59.31 | 2025 | |
| Genzyme Corporation | $53.66 | 2025 | |
| Medtronic, INC. | $50.38 | 2024 | Illumisite |
| Inari Medical, INC. | $49.69 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $45.73 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Avadel Cns Pharmaceuticals, LLC | $40.86 | 2025 | Lumryz |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $29.51 | 2024 | Inspire |
| Grifols USA, LLC | $24.05 | 2025 | Prolastin-C Liquid |
| Insmed, INC. | $19.85 | 2025 | Arikayce |
| Takeda Pharmaceuticals U.S.A., INC. | $16.78 | 2025 | Glassia |
| Merck Sharp & Dohme LLC | $15.24 | 2025 | Zerbaxa |
| Ethicon INC. | $13.56 | 2024 | Monarch Platform |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Binav Shrestha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.